TYTularam Yadav

Tularam Yadav

*This is an algorithmically generated author record based on publicly available information.

Tularam Yadav has a total of 46 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Unusual Etiology of Budd‐Chiari Syndrome in an Adolescent: A Case of Combined Thrombophilic Disorder

    by Santosh Sah, Rumaisa Riaz, Afsheen Khan, Tularam Yadav, Kirshan Lal, Hussain Haider Shah

    Budd‐Chiari syndrome (BCS) is an uncommon but potentially life‐threatening hepatic vascular disorder resulting from obstruction of the hepatic venous outflow. While it predominantly affects adults, pediatric and adolescent presentations are rare, particularly those associated with inherited thrombophilia. Early diagnosis and appropriate intervention are essential to prevent complications such as portal hypertension, hepatic ischemia, and liver failure. We describe the case of a 15‐year‐old female who presented with progressive abdominal distension, right upper quadrant pain, and bilateral lower limb edema. Imaging studies, including ultrasound and contrast‐enhanced CT, revealed hepatic venous obstruction with thrombus extension into the portal, superior mesenteric and splenic veins, and gross ascites. Laboratory findings indicated elevated inflammatory markers and impaired liver function. A detailed thrombophilia workup demonstrated deficiencies in protein C and antithrombin III and a Factor V Leiden mutation, confirming a hypercoagulable state as the underlying etiology. The patient was diagnosed with subacute Budd‐Chiari Syndrome secondary to inherited thrombophilia. She was initiated on anticoagulation therapy with warfarin, later transitioned to rivaroxaban, and managed with diuretics and dietary modifications. Clinical improvement was achieved, and the patient was referred to a liver transplant center for ongoing evaluation.


  • Open Access

    Early‐Onset Hypopigmented Mycosis Fungoides in a Young Female: Navigating Diagnostic Delays and Treatment Complexities—A Case Report

    by Ravi Das, Fnu Venjhraj, Shilpa Dahara, Naren Kumar Matlani, Meva Ram, Tularam Yadav

    Hypopigmented mycosis fungoides (HMF) is a variant of mycosis fungoides (MF). It is classified as a low‐grade lymphoproliferative disorder and is often challenging to diagnose, especially in young, darker‐skinned patients, due to its resemblance to benign conditions such as pityriasis alba, idiopathic macular hypomelanosis (IMH), parapsoriasis, postinflammatory hypopigmentation, vitiligo, and leprosy. We report a case of HMF in a 22‐year‐old Pakistani female presenting with progressive hypopigmented patches and plaques primarily on the back, groin, and trunk. The importance of early assessment in atypical HMF presentations is underscored by the delayed diagnosis despite multiple consultations. The diagnosis was confirmed through skin biopsy findings, which demonstrated CD4+ T‐cell dominance. The first treatment, which included topical steroids and narrow‐band UVB phototherapy, resulted in a partial remission. However, the patient relapsed within a few months and needed to be treated with methotrexate. This example highlights the importance of careful clinical, histological, and immunohistochemical testing for timely HMF detection as well as the need for vigilant monitoring to effectively manage recurrences.

  • Open Access

    Benzene and human health: a comprehensive review of carcinogenic risks, mechanisms, and preventive strategies

    by Tashvin Paul, Tanya Paul, Shailendra Katwal, Parinita Aroori, Prachi Dawer, Harsh Bhatia, Temiloluwa Njideaka-Kevin, Prathima Guntipalli, Tularam Yadav

    Industries widely utilize benzene in the production of plastics, resins, and fibers. It is also present in cigarette smoke, gasoline, and motor vehicle exhaust. Unfortunately the widespread use is also associated with a significant risk of malignancies. Leukemias, lymphomas, and lung cancers are among the malignancies commonly linked to benzene exposure. Studies have described various pathophysiological mechanisms involving interactions between the immune system, stem cells, and oxidative stress. These changes are linked to chromosomal abnormalities and the development of a mutator phenotype. In addition to cancers, benzene is associated with the acceleration of lifestyle diseases such as cardiovascular disease and metabolic syndrome. Other carcinogens include ultraviolet radiation, processed meat, and various air pollutants. Authorities have implemented various regulations have been established to limit exposure to such hazardous chemicals. Additionally, recommendations have been issued regarding actions to take in the event of acute benzene exposure. By raising awareness and enforcing stringent laws, the incidence of benzene-associated cancers can decline.


  • Open Access

    Twice-Yearly Injectable Pre-Exposure Prophylaxis With Lenacapavir: Redefining Adherence and Access in the Global Fight Against HIV

    by Santosh Sah, Ureeba Iqbal, Trilok Mishra, Najeeb Ullah, Tularam Yadav

    Despite progress in human immunodeficiency virus (HIV) prevention, global targets remain unmet, with over 1.3 million new infections annually—driven by adherence challenges, stigma, and daily pill fatigue linked to oral pre-exposure prophylaxis (PrEP). Lenacapavir, a long-acting injectable capsid inhibitor approved by the FDA in June 2025, offers transformative twice-yearly subcutaneous dosing with sustained efficacy and minimal drug interactions. PURPOSE 1 and 2 trials demonstrated near-complete protection across cisgender women, men who have sex with men, transgender individuals, and adolescents, highlighting its potential to overcome barriers to PrEP uptake. Its high acceptability, infrequent dosing, and pharmacologic durability make it ideal for individuals facing stigma, mobility constraints, or limited healthcare access. WHO's endorsement marks a pivotal milestone, but real-world implementation must address cold-chain logistics, cost, provider training, and systemic inequities. Integrating lenacapavir through decentralized delivery models, differentiated care, and inclusive national guidelines will be key to equitable access, decreasing gaps and advancing epidemic control.


  • Open Access

    Dengue vaccine rollout in India: lessons for Pakistan’s public health preparedness

    by Santosh Sah, Areeba Ahsan, Rabeea Tariq, Tularam Yadav

    Dengue fever continues to challenge public health systems across South Asia, with Pakistan and India facing recurrent outbreaks marked by rising case numbers and hospitalizations. While conventional approaches, such as vector control and public awareness campaigns, have had limited long-term success, vaccines now offer a promising complement to existing strategies. India’s recent approval of the TAK-003 (Qdenga) dengue vaccine marked a turning point in regional prevention efforts. Through strategic partnerships, tiered pricing, improved cold chain infrastructure, and the use of seroprevalence data to guide rollout, India has developed a framework that balances innovation with accessibility. In contrast, Pakistan’s dengue response remains largely reactive, with critical gaps in surveillance, diagnostic capacity, and institutional readiness. Drawing lessons from India’s experience, this article highlights key areas for policy improvement in Pakistan. These include investing in vaccine delivery infrastructure, streamlining regulatory processes, strengthening technical advisory bodies and promoting transparent communication to build public trust. Integrating school-based immunization programs and mobile outreach for underserved populations can ensure equitable access. With a phased, evidence-based approach rooted in local epidemiology, Pakistan has the opportunity to incorporate dengue vaccination into its broader public health strategy, reducing disease burden and increasing preparedness for future outbreaks.


  • Open Access

    Pakistan’s path forward in DR-TB management: insights from global implementation of BPaL/BPaLM regimen

    by Santosh Sah, Areeba Ahsan, Tularam Yadav

    Drug-resistant tuberculosis (DR-TB) is a serious public health threat, and Pakistan is one of the most impacted nations. The long treatment duration of traditional regimens puts a great burden on healthcare systems, especially in resource-constrained environments. Accordingly, the World Health Organization launched the Bedaquiline, Pretomanid, and Linezolid (BPaL)/Bedaquiline, Pretomanid, Linezolid, and Moxifloxacin (BPaLM) regimen – a 6-month, all-oral therapy consisting of BPaLM. With stated success rates as high as 90%, these regimens present an exciting alternative to traditional treatments. Yet, their integration into current treatment programs is hindered by policy lags, poor diagnostic infrastructure, and difficulty in maintaining patient compliance. This brief communication explores the promise of BPaL/BPaLM to enhance DR-TB cure rates while pinpointing major hurdles to its use in Pakistan. Enhancing diagnostic capacity, upgrading healthcare infrastructure, and accelerating policy adjustment are crucial steps toward maximizing DR-TB management in high-burden countries.


  • Open Access

    ”Early-Onset Hypopigmented Mycosis Fungoides in a Young Female: Navigating Diagnostic Delays and Treatment Complexities – A Rare Case Report”

    by Ravi Das, Fnu Venjhraj, Shilpa Dahara, Naren Matlani, Meva Ram, Tularam Yadav

    Introduction:Hypopigmented Mycosis Fungoides(HMF) is the most prevalent form of cutaneous T-cell lymphoma and is classified as a low-grade lymphoproliferative disease. It starts in peripheral epidermotropic T-cells, most especially memory T-cells (CD45RO+), which express the CD4+ immunophenotype and T-cell receptor (TCR) [1], [2].It initially exhibit erythematous patches and/or plaques, which are indicative of the early stages of HMF. Clinically, the patches and plaques are generally seen on sun-protected parts of the body, vary in size and form, and usually have a scaly surface with varying degrees of atrophy [3]. HMF can develop gradually over a number of phases, albeit not all patients experience every stage. Skin disorders arise when malignant T cells migrate from the blood into the skin; the skin cells themselves are not cancerous. Although the exact cause is still unknown, it seems to be caused by long-term antigenic stimulation that causes T-lymphocyte clonal growth and epidermal infiltration. However, it is still unclear what mechanism or components are involved in this antigenic activation. Most frequently, patches appear on the breasts, buttocks, upper thighs, and lower abdomen. They may stay constant throughout time or vanish and then resurface. Some afflicted people develop plaques, the subsequent stage of mycosis fungoides, from patches [4], [5]. MF mostly affects men, with a sex ratio of 1.6:1 to 2:1, and usually strikes people in their late fifties. Most of the patients are Caucasian. The Instituto Nacional de Câncer (INCA) released an estimate for non-Hodgkin lymphomas (NHL) in 2016 that showed 5,210 new cases in males and 5,030 in women [5]. Between 1992 and 2001, 1610 NHL cases were diagnosed in Pakistan’s Department of Pathology at Aga Khan University Hospital. Of these, 133 (8.26%) had cutaneous involvement, while 14.5% were diagnosed as MF. MF contributed 0.86% of total NHLs. The age ranged from 28 to 73 years, with a median age of 52.5 years and a male-to-female ratio of 2.5:1. Four cases had generalized body lesions [6].This case highlights a diagnostic issue since hypopigmented mycosis fungoides (HMF) can resemble other disorders like vitiligo and leprosy. It manifests in a unique way in a young female with darker skin. Since it can mimic benign hypopigmented lesions, HMF is relatively uncommon and frequently misdiagnosed, especially in patients with darker skin. This delay in identification highlights how crucial it is to take MF into account in atypical presentations and how immunohistochemical staining and histological investigation are necessary to confirm the diagnosis in these situations. This case has been reported according to CARE CRITERIA [7].

  • Open Access

    Zika virus disease: an alarming situation resurfacing on the radar – a short communication

    by Sanobar Shariff, Burhan Kantawala, Nakyanzi Hamiidah, Tularam Yadav, Abubakar Nazir, Olivier Uwishema

    Background / Introduction: On 13th of December, 2022, a five-year-old girl from Karnataka, India, tested positive for Zika virus. The first Zika virus was isolated from the serum of a rhesus monkey in the Zika Forest of Uganda, in 1947. Zika virus was largely dormant for about 70 years before suddenly resurfacing across all of America, from Brazil to the Pacific Islands and is connected to a grouping of microcephaly phenotypes based on a complete virus genome analysis. All of the aforementioned research provides an overview of the migration of this virus from the Americas to continental Africa via mosquitoes. The current study therefore aims to evaluate the virologic characteristics, prophylaxis, transmitting mechanisms, diagnosis, clinical manifestations and treatment of ZIKV infection in light of the virus’s widespread dissemination and deadly nature. Aim: The investigation’s findings aim to demonstrate that in order to prevent further outbreaks, there is a national requirement for active epidemiological and entomological observation of Zika. Materials and methods: Data was extracted from academic journals of medicine published in MEDLINE, PubMed, ScienceDirect, Ovid and Embase inventory databases with a predetermined search strategy. Articles considering Zika virus and its clinical manifestations, especially neurological, were included. Results: The Zika virus has been declared as a public health emergency of global significance by the World Health Organization (WHO). It is of alarming concern that it is now one of the most prevalent infectious diseases associated with birth abnormalities discovered in the past five decades. The onset and accelerated spread of disease to other parts of the world is attributed to migration of infected hosts and climate change. Rapid laboratory diagnosis, evaluation of serological techniques and virus isolation are urgently needed along with newer modalities such as mathematical modeling as prediction devices to curb this issue. Due to its grave neurological manifestations, it is mandated to engineer peptide therapies and a virus-specific vaccination to treat this neurotropic virus. Conclusion: There is currently no vaccination against Zika virus infection. If societies are not adequately prepared, the epidemiological wave will have an impact on the work force and could pose a serious threat. To alleviate the significant cost on health systems and manage its promotion globally, improved investigation and response activities are needed.


  • Prevalence of irritable bowel syndrome (IBS) and functional dyspepsia (FD) and their relationship with generalized anxiety disorder (GAD) among medical students in Karachi

    by Mahnoor Javed, Tularam Yadav, Jibran Shakil, Syed Tafazzul Haider Zaidi, Mehwish Zehra

    Objective: To assess the prevalence of inflammatory bowel syndrome and functional dyspepsia in medical students and their relationship with generalised anxiety disorder and other relevant factors. Method: The descriptive cross-sectional study was conducted in Karachi from August to November 2020 after approval from the ethics review board of Jinnah Sindh Medical University, and comprised students of either gender aged at least 18 years from different medical colleges in the city. Data was collected using validated tools Rome III criteria for inflammatory bowel syndrome and functional dyspepsia and Generalised Anxiety Disorder-7. Data was analysed using SPSS 26. Results: Of the 305 subjects, 185(60.70%) were male and 120(39.30%) were female. The overall mean age was 21.43±2.13 years. The prevalence of inflammatory bowel syndrome was 17(5.57%), while that of functional dyspepsia was 2(0.66%). Further, 122(40%) students had minimal anxiety, 112(36.72%) mild, 43(14.10%) moderate and 28(9.18%) had severe anxiety. There was no significant relationship of either inflammatory bowel syndrome or functional dyspepsia diagnosis with generalised anxiety disorder (p>0.05), but a significant relationship existed between inflammatory bowel syndrome diagnosis and generalised anxiety disorder score (p=0.041). Significant relationships were found between inflammatory bowel syndrome diagnosis and use of non-steroidal anti-inflammatory drugs. The relationship of generalised anxiety disorder diagnosis with gender and probiotic use was significant (p<0.05), and so was the relationship of generalised anxiety disorder score with gender and level of physical activity (p<0.05). Conclusion: Medical students with a higher generalised anxiety disorder score and those who used non-steroidal anti-inflammatory drugs frequently had a higher likelihood of developing inflammatory bowel syndrome. Key Words: Anxiety, Functional dyspepsia, Irritable bowel syndrome, Medical students.


  • Open Access

    Postpartum Depression: Prevalence and Associated Risk Factors Among Women in Sindh, Pakistan

    by Tularam Yadav, Rija Shams, Amir F. Khan, Hadiya Azam, Masroor Anwar, Tooba Anwar, Charaghan Siddiqui, Kiran Abbas, Mahnoor Sukaina, Shamas Ghazanfar

    Postpartum depression (PPD) is defined as the onset of depressive symptoms within six weeks of childbirth. PPD is more common in resource-constrained countries as compared to developed countries. The study aimed to evaluate the factors associated with PPD among women in Sindh, Pakistan. A multi-centre, cross-sectional study was conducted at three major tertiary care setups in Sindh, Pakistan. All women presenting to the outpatient department within six weeks of giving live birth were eligible to participate. All women who had stillbirths, abortions, or were treated for a past psychiatric illness or neurological disease were excluded from the study. The Edinburgh postpartum depression scale (EPDS) was used as a screening tool. All socio-demographic factors were documented in a predefined pro forma. The data was analyzed using Statistical Package for Social Sciences (SPSS, Version 26, IBM, Chicago, IL). According to the Edinburgh postpartum depression scale (EPDS), the incidence of postpartum depression in the current study population was 19.3%. Of these, 12 (3.3%) women had persistently thought about self-harming. Over 100 women did not receive any formal education, constituting the majority of the study population. Formula milk feeding of the newborn was significantly associated with an increased frequency of postpartum depression (p= 0.0001). The current study highlights the significant burden of postpartum depression in Pakistan. However, the present study failed to find any significant risk factors associated with postpartum depression. Only formula milk feeding was significantly associated with a higher frequency of PPD among study patients.